254 related articles for article (PubMed ID: 31369093)
1. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma.
Zhang Y; Liu YT; Tang H; Xie WQ; Yao H; Gu WT; Zheng YZ; Shang HB; Wang Y; Wei YX; Wu ZR; Wu ZB
J Clin Endocrinol Metab; 2019 Dec; 104(12):6345-6356. PubMed ID: 31369093
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours.
Wu ZR; Yan L; Liu YT; Cao L; Guo YH; Zhang Y; Yao H; Cai L; Shang HB; Rui WW; Yang G; Zhang XB; Tang H; Wang Y; Huang JY; Wei YX; Zhao WG; Su B; Wu ZB
Nat Commun; 2018 Nov; 9(1):4624. PubMed ID: 30397197
[TBL] [Abstract][Full Text] [Related]
3. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists.
Wu Z; Zheng Y; Xie W; Li Q; Zhang Y; Ren B; Cai L; Cheng Y; Tang H; Su Z; Wu ZB
Mol Cell Endocrinol; 2020 Dec; 518():111033. PubMed ID: 32946927
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
6. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
8. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
9. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients.
Tang S; Zheng K; Tang Y; Li Z; Zou T; Liu D
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180050
[TBL] [Abstract][Full Text] [Related]
11. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
Zhou H; Shen W; Zou H; Lv Q; Shao P
J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
[TBL] [Abstract][Full Text] [Related]
13. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X
Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702
[TBL] [Abstract][Full Text] [Related]
14. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions.
Li X; Liu R; Wang Y; Zhu W; Zhao D; Wang X; Yang H; Gurley EC; Chen W; Hylemon PB; Zhou H
Cells; 2020 Jan; 9(1):. PubMed ID: 31940841
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
Zhang Y; Tan Y; Wang H; Xu M; Xu L
Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
Yan P; Su Z; Zhang Z; Gao T
Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
[TBL] [Abstract][Full Text] [Related]
18. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression.
Yue X; Dong C; Ye Z; Zhu L; Zhang X; Wang X; Mo F; Li Z; Pan B
Metab Brain Dis; 2021 Jan; 36(1):123-132. PubMed ID: 32880813
[TBL] [Abstract][Full Text] [Related]
20. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.
Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB
Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
